Bydureon combined with Metformin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Underdose Life Threatening 1/1/2006 59 Male 230 lb 6/15/2012 Consumer United States
Primary
Secondary
Concomitant
Abortion Spontaneous Other Serious 7/4/2012 36 Female 196 lb 8/20/2012 Consumer Germany
Primary
Concomitant
Adenocarcinoma Pancreas Other Serious 12/16/2010 57 Female 1/16/2013 Other Health Professional Us
Primary
Secondary
Concomitant
Vomiting Hospitalization 3/19/2012 Female 243 lb 10/23/2012 Physician Se
Primary
Concomitant
Coronary Angioplasty Hospitalization 5/10/2010 Male 9/7/2012 Physician De
Primary
Secondary
Concomitant
Blood Glucose Increased Other Serious 6/25/2012 60 Female 310 lb 9/10/2012 Physician Us
Primary
Concomitant
Tremor Hospitalization 7/4/2012 59 Female 208 lb 9/21/2012 Physician Us
Primary
Concomitant
Injection Site Abscess Hospitalization 7/15/2012 Male 9/13/2012 Physician De
Primary
Concomitant
Exposure During Pregnancy Other Serious 6/2012 36 Female 196 lb 9/26/2012 Physician De
Primary
Concomitant
Hydrocholecystis Hospitalization 5/21/2012 61 Female 194 lb 10/23/2012 Consumer Dk
Primary
Concomitant
Weight Decreased Other Serious 8/2011 Female 145 lb 8/30/2012 Consumer Us
Primary
Secondary
Concomitant
Vomiting Hospitalization 4/24/2012 56 Male 9/7/2012 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious Male 9/10/2012 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious Female 180 lb 9/11/2012 Consumer Us
Primary
Secondary
Concomitant
Injection Site Ulcer Other Serious 8/31/2012 59 Female 149 lb 8/31/2012 Us
Primary
Concomitant
Weight Increased Other Serious 7/2012 Female 115 lb 12/11/2012 Consumer Us
Primary
Secondary
Concomitant
Vomiting Other Serious 9/3/2012 62 Female 178 lb 9/14/2012 Consumer Us
Primary
Concomitant
Pancreatic Disorder Other Serious 8/15/2012 40 Male 9/14/2012 Consumer De
Primary
Concomitant
Weight Decreased Other Serious 8/2012 Male 245 lb 9/14/2012 Consumer Us
Primary
Secondary
Concomitant
Injection Site Nodule Hospitalization 8/2012 61 Male 11/21/2012 Physician De
Primary
Concomitant
Erythema Multiforme Other Serious 7/14/2012 61 Female 235 lb 1/11/2013 Physician Gb
Primary
Concomitant
Pulmonary Embolism Other Serious 9/12/2012 50 Male 337 lb 10/11/2012 Consumer Gb
Primary
Concomitant
Pneumonia Other Serious 9/29/2012 47 Female 257 lb 10/15/2012 Consumer Us
Primary
Concomitant
Gastrooesophageal Reflux Disease Other Serious 8/15/2012 65 Male 212 lb 10/17/2012 Consumer Gb
Primary
Concomitant
Myocardial Infarction Other Serious 9/3/2012 46 Male 11/16/2012 Consumer Us
Primary
Concomitant
Cardiac Operation Other Serious 7/2012 Male 10/19/2012 Consumer De
Primary
Concomitant
Colitis Ulcerative Hospitalization 11/1/2011 67 Female 172 lb 1/10/2013 Consumer De
Primary
Concomitant
Weight Decreased Other Serious 5/2009 Female 11/9/2012 Consumer Us
Primary
Secondary
Concomitant
Spinal Fusion Surgery Other Serious Male 10/25/2012 Consumer Us
Primary
Secondary
Concomitant
Pain In Extremity Female 206 lb 10/26/2012 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 4/2012 Female 142 lb 10/23/2012 Consumer Us
Primary
Concomitant
Pancreatitis Acute Hospitalization 10/18/2012 Male 322 lb 1/30/2013 Consumer De
Primary
Concomitant
Weight Decreased Hospitalization 9/2/2012 67 Male 226 lb 11/2/2012 Consumer Us
Primary
Concomitant
Renal Failure Chronic Other Serious 60 Female 12/7/2012 Consumer Us
Primary
Concomitant
Clostridium Difficile Infection 5/18/2012 38 Female 202 lb 11/8/2012 Other Health Professional Us
Primary
Concomitant
Injection Site Haemorrhage Hospitalization 11/3/2012 57 Male 220 lb 11/27/2012 Consumer Us
Primary
Concomitant
Diabetic Ketoacidosis Hospitalization 11/14/2012 24 Male 11/26/2012 Consumer Us
Primary
Concomitant
Sciatica Other Serious Female 179 lb 12/21/2012 Physician Us
Primary
Secondary
Concomitant
Somnolence Other Serious 11/2012 Female 287 lb 11/29/2012 Consumer Us
Primary
Concomitant
Tremor Other Serious 11/28/2012 45 Female 252 lb 1/25/2013 Consumer Us
Primary
Concomitant
Hypoaesthesia Hospitalization 10/11/2012 Female 1/4/2013 Physician De
Primary
Concomitant
Pancreatitis Other Serious Male 323 lb 12/5/2012 Consumer Ie
Primary
Concomitant
Vomiting Hospitalization 10/21/2012 Female 1/28/2013 Physician De
Primary
Concomitant
Wrong Technique In Drug Usage Process Other Serious 6/21/2012 60 Female 12/5/2012 Physician Us
Primary
Concomitant
Dyspnoea Other Serious 11/21/2012 50 Male 280 lb 12/7/2012 Consumer Us
Primary
Concomitant
Hernia Repair Other Serious Male 562 lb 12/7/2012 Consumer Us
Primary
Concomitant
Skin Mass Hospitalization 12/1/2012 Male 12/14/2012 Physician De
Primary
Concomitant
Throat Irritation Other Serious 11/2/2012 70 Female 206 lb 12/17/2012 Other Health Professional Us
Primary
Concomitant
Vomiting Other Serious 11/6/2012 64 Male 195 lb 12/20/2012 Consumer Us
Primary
Concomitant
Vomiting Other Serious 10/15/2012 71 Female 195 lb 12/26/2012 Consumer Se
Primary
Concomitant
Sinusitis 12/2012 60 Male 213 lb 2/4/2013 Other Health Professional Us
Primary
Concomitant
Injection Site Extravasation 12/17/2012 75 Male 2/21/2013 Consumer Se
Primary
Concomitant
Skin Mass Other Serious 48 Male 270 lb 1/3/2013 Consumer Gb
Primary
Concomitant
Weight Decreased Other Serious 2009 68 Male 175 lb 1/12/2013 Consumer Us
Primary
Secondary
Concomitant
Vomiting Other Serious 1/7/2013 63 Male 250 lb 2/28/2013 Physician Us
Primary
Concomitant
Nausea 7/27/2012 28 Male 1/30/2013 Consumer Country Not Specified
Primary
Concomitant
Osteopenia 59 Female 1/31/2013 Consumer Country Not Specified
Primary
Concomitant
Weight Increased Other Serious Male 245 lb 2/14/2013 Consumer Us
Primary
Concomitant
Nephropathy Toxic Other Serious Female 3/8/2013 Consumer Us
Primary
Concomitant
Vomiting Other Serious 1/21/2013 68 Male 1/29/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 12/2012 Female 177 lb 1/30/2013 Consumer Us
Primary
Concomitant
Off Label Use Other Serious 1/2013 Female 3/14/2013 Physician Us
Primary
Concomitant
Somnolence Other Serious 1/14/2013 Male 3/15/2013 Consumer De
Primary
Concomitant
Weight Decreased Other Serious 12/24/2012 69 Female 189 lb 2/21/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 12/24/2012 69 Female 189 lb 2/21/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 2012 Female 230 lb 2/8/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Increased 2012 Male 212 lb 2/25/2013 Consumer Us
Primary
Concomitant
Weight Increased 2012 Male 212 lb 2/25/2013 Consumer Us
Primary
Concomitant
Off Label Use Other Serious 1/21/2013 58 Female 3/28/2013 Consumer Us
Primary
Concomitant
Staphylococcal Infection Other Serious 2/13/2013 33 Female 2/25/2013 Consumer Us
Primary
Concomitant
Angina Unstable Hospitalization 10/2011 62 Male 202 lb 1/17/2013 Consumer Us
Primary
Concomitant
Blood Glucose Increased Other Serious 1/12/2013 55 Female 1/25/2013 Consumer Us
Primary
Concomitant
Tremor Other Serious 2/17/2013 66 Female 2/27/2013 Consumer Us
Primary
Concomitant
Mood Swings 12/18/2012 57 Male 197 lb 2/28/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious Male 230 lb 2/28/2013 Consumer Us
Primary
Secondary
Concomitant
Swelling Face Other Serious 1/2013 Female 175 lb 2/28/2013 Consumer Us
Primary
Concomitant
Palpitations Hospitalization 2/2013 Female 290 lb 3/5/2013 Consumer Us
Primary
Concomitant
Underdose Other Serious 2/23/2013 67 Female 132 lb 3/5/2013 Consumer Us
Primary
Concomitant
Vomiting Other Serious 12/2012 Female 168 lb 3/8/2013 Consumer Us
Primary
Concomitant
Wound Infection Staphylococcal Other Serious 6/2012 Female 214 lb 3/7/2013 Consumer Us
Primary
Secondary
Concomitant
Endometrial Cancer Other Serious 54 Female 3/7/2013 Consumer Gb
Primary
Secondary
Concomitant
Nausea Other Serious 1/2013 52 Male 271 lb 4/1/2013 Consumer Us
Primary
Secondary
Concomitant
Vomiting 2/27/2013 60 Female 3/13/2013 Other Health Professional Us
Primary
Concomitant
Pneumonia Other Serious 12/2012 Female 3/20/2013 Consumer Us
Primary
Concomitant
Injection Site Haemorrhage Other Serious 2/2013 Male 319 lb 3/21/2013 Consumer Us
Primary
Secondary
Concomitant
Epistaxis Life Threatening 7/5/2012 62 Male 287 lb 10/29/2012 Consumer Gb
Primary
Concomitant
Hallucination, Visual Other Serious Female 3/22/2013 Consumer Us
Primary
Secondary
Concomitant
Syncope Other Serious 10/2/2012 42 Female 196 lb 11/2/2012 Consumer Gb
Primary
Concomitant
Venous Insufficiency Other Serious 3/14/2013 Female 183 lb 3/22/2013 Consumer Us
Primary
Concomitant
Pancreatic Mass Other Serious 61 Male 3/29/2013 Consumer Us
Primary
Concomitant
Lymphoma Other Serious 2010 Female 148 lb 4/3/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 12/2012 70 Male 220 lb 4/3/2013 Consumer Us
Primary
Concomitant
Urticaria Other Serious 3/15/2013 47 Female 180 lb 4/2/2013 Consumer Us
Primary
Concomitant
Wound Infection Staphylococcal Hospitalization 6/2012 63 Female 214 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Lung Disorder Hospitalization 12/2012 69 Female 4/16/2013 Consumer Us
Primary
Concomitant
Pancreatitis Hospitalization 63 Male 205 lb 4/23/2013 Consumer Us
Primary
Concomitant
Pancreatitis Hospitalization 9/2012 59 Male 6/27/2013 Consumer Us
Primary
Concomitant
Injection Site Pruritus Other Serious 52 Female 5/30/2013 Other Health Professional Gb
Primary
Secondary
Injection Site Pruritus Other Serious 52 Female 6/19/2013 Other Health Professional Gb
Primary
Secondary
Concomitant
Pyrexia Hospitalization 2/12/2013 35 Male 269 lb 4/28/2013 Physician De
Primary
Concomitant
Weight Decreased Hospitalization 53 Male 205 lb 4/29/2013 Consumer Us
Primary
Concomitant
Product Quality Issue Hospitalization 4/2013 64 Male 212 lb 5/17/2013 Consumer Us
Primary
Concomitant
Lipohypertrophy Other Serious 1/24/2013 59 Female 247 lb 5/7/2013 Consumer Gb
Primary
Concomitant
Underdose Other Serious 2/23/2013 67 Female 132 lb 5/25/2013 Consumer Us
Primary
Concomitant
Nausea Other Serious 2013 59 Male 240 lb 5/14/2013 Consumer Us
Primary
Concomitant
Injection Site Pain Other Serious 1/2013 39 Female 152 lb 5/15/2013 Consumer Country Not Specified
Primary
Concomitant
Pancreatitis Other Serious 4/18/2013 64 Male 5/15/2013 Consumer Us
Primary
Concomitant
Off Label Use 70 Female 158 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Haemorrhage Other Serious 2/2013 54 Male 319 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Vomiting Disability 12/2012 69 Female 168 lb 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 2/2013 57 Male 230 lb 5/25/2013 Consumer Us
Primary
Concomitant
Vomiting 2/2013 Male 5/25/2013 Consumer Us
Primary
Concomitant
Blood Glucose Increased 3/11/2013 Male 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule 1/2013 56 Female 130 lb 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 3/10/2013 55 Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased Female 5/25/2013 Consumer Us
Primary
Concomitant
Pruritus 2/2013 59 Female 180 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule 70 Female 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 3/5/2013 67 Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased 2/2012 68 Female 5/25/2013 Consumer Us
Primary
Concomitant
Joint Swelling 1/28/2013 45 Male 5/25/2013 Physician Us
Primary
Concomitant
Pyrexia 2/28/2013 61 Female 5/25/2013 Consumer Us
Primary
Concomitant
Salivary Duct Obstruction 2/22/2013 49 Female 187 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pruritus 49 Female 309 lb 5/25/2013 Consumer Us
Primary
Concomitant
Vomiting 3/7/2013 58 Female 204 lb 5/25/2013 Consumer Us
Primary
Concomitant
Tremor 3/4/2013 Female 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pain 53 Male 240 lb 5/25/2013 Consumer Us
Primary
Concomitant
Abdominal Distension 60 Male 190 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pain 52 Female 5/25/2013 Consumer Us
Primary
Concomitant
Flatulence 3/1/2013 56 Female 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule 2/2013 73 Male 190 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pruritus 54 Male 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pruritus 62 Male 5/25/2013 Consumer Us
Primary
Concomitant
Weight Increased 53 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Palpitations 12/5/2012 60 Female 258 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Mass 67 Female 5/25/2013 Consumer Us
Primary
Concomitant
Weight Decreased 1/26/2013 Female 5/25/2013 Consumer Us
Primary
Concomitant
Overdose 3/17/2013 Female 5/25/2013 Consumer Us
Primary
Concomitant
Vomiting 63 Female 170 lb 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 3/4/2013 59 Male 210 lb 5/25/2013 Consumer Us
Primary
Concomitant
Weight Decreased 2/2013 59 Male 263 lb 5/25/2013 Consumer Us
Primary
Concomitant
Tremor 3/13/2013 60 Female 5/25/2013 Consumer Us
Primary
Concomitant
Rash Generalised 35 Female 5/25/2013 Consumer Us
Primary
Concomitant
Urticaria 67 Male 214 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule 65 Male 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 11/2012 64 Male 194 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Haemorrhage 3/14/2013 80 Female 5/25/2013 Consumer Us
Primary
Concomitant
Venous Insufficiency Other Serious 3/14/2013 Female 183 lb 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pain 3/10/2013 63 Female 226 lb 5/25/2013 Consumer Us
Primary
Concomitant
Blood Glucose Decreased Hospitalization 10/15/2012 63 Female 154 lb 1/4/2013 Registered Nurse Us
Primary
Concomitant

Drug Data